Compare ESPR & NFGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESPR | NFGC |
|---|---|---|
| Founded | 2008 | 2016 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 816.9M | 760.5M |
| IPO Year | 2013 | 2021 |
| Metric | ESPR | NFGC |
|---|---|---|
| Price | $3.19 | $1.47 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.75 | N/A |
| AVG Volume (30 Days) | ★ 16.8M | 1.5M |
| Earning Date | 05-07-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 60.71 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $403,135,000.00 | N/A |
| Revenue This Year | N/A | $3,542.00 |
| Revenue Next Year | $12.81 | $118.57 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 21.31 | N/A |
| 52 Week Low | $1.11 | $1.40 |
| 52 Week High | $4.18 | $3.59 |
| Indicator | ESPR | NFGC |
|---|---|---|
| Relative Strength Index (RSI) | 67.43 | 39.10 |
| Support Level | $3.16 | $1.45 |
| Resistance Level | $3.26 | $1.75 |
| Average True Range (ATR) | 0.02 | 0.08 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 78.57 | 19.40 |
Esperion Therapeutics Inc is a commercial-stage biopharmaceutical company currently focused on bringing new medicines to patients that address unmet medical needs. It has developed and is commercializing U.S. Food and Drug Administration, or FDA, approved oral, once-daily, non-statin medicines for patients who are at risk for cardiovascular disease (or CVD and are struggling with elevated low-density lipoprotein cholesterol, or LDL-C. The Company views its operations and manages its business in one operating segment, which is the business of researching, developing, and commercializing therapies for the treatment of patients with elevated LDL-C. The company depends almost entirely on the success of two products, the bempedoic acid tablet and the bempedoic acid/ezetimibe combination tablet.
New Found Gold Corp is a mineral exploration company engaged in the acquisition, exploration and evaluation of resource properties with a focus on gold properties located in the Provinces of Newfoundland and Labrador and Ontario, Canada. The Companies exploration is focused on discovering and delineating gold resources. The Company has one material property: the Queensway Project located in Newfoundland, Canada (the Queensway Project).